S100B and myeloid sarcoma: In order to further verify this hypothesis, we used arundic acid (AA; ONO 2506), a known inhibitor of astrocytic S100B synthesis [14], in an chronic progressive MS model (P-EAE mice) [15], which reproduces a severe form of MS with slow continuous worsening of neurological decline.